Acute dilation brought about by the dietary flavonoid quercetin in coronary arterioles has been described earlier, but no information is available on its chronic effects. Male Wistar rats (body weight about 190 g) were divided to two groups: the quercetin-treated group (n=22) had quercetin supplementation of approximately 30 mg/kg/day, whereas the control group (n=20) had none. After eight weeks of treatment, intramural coronary arterioles with identical passive diameters (178+/-14 microm and 171+/-9 microm) were prepared and their biomechanics and pharmacological reactivities were tested using pressure arteriography ex vivo. The spontaneous tone of quercetin-treated arteries was higher (16.5+/-1.9 % vs. 12.9+/-0.9 %), which resulted in a reduced lumen size (144+/-9 microm vs. 167+/-12 microm), thicker vascular wall (22.6+/-1.8 microm vs. 17.4+/-1.6 microm) and decreased tangential wall stress (16.8+/-1.1 kPa vs. 20.5+/-1.6 kPa) in supplemented animals (in spontaneous tone at 50 mm Hg, p<0.01 in all these comparisons). Elevated basal NO release resulted in increased endothelial dilation in quercetin-treated animals, especially at higher intraluminal pressures (10.8+/-2.5 % vs. 5.7+/-1.3 % at 70 mm Hg, p<0.01). We found remodeling of the geometry of coronary arterioles to ensure higher dilatory reserve and nitrogen monoxide production, as well as lowered elastic stress of the vessel wall.

Department of Physiology Semmelweis University Budapest Hungary

Faculty of Pharmacy University of Palermo Palermo Italy

Institute of Clinical Experimental Research Semmelweis University Budapest Hungary

000      

00000naa a2200000 a 4500

001      

bmc18021058

003      

CZ-PrNML

005      

20180621135911.0

007      

ta

008      

180611s2017 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.933384 $2 doi

035    __

$a (PubMed)28406703

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Monori-Kiss, A. $u Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary

245    10

$a Chronic administration of quercetin induces biomechanical and pharmacological remodeling in the rat coronary arteries / $c A. Monori-Kiss, F. Kiss, J. M. Restifo, E. Monos, G. L. Nadasy

520    9_

$a Acute dilation brought about by the dietary flavonoid quercetin in coronary arterioles has been described earlier, but no information is available on its chronic effects. Male Wistar rats (body weight about 190 g) were divided to two groups: the quercetin-treated group (n=22) had quercetin supplementation of approximately 30 mg/kg/day, whereas the control group (n=20) had none. After eight weeks of treatment, intramural coronary arterioles with identical passive diameters (178+/-14 microm and 171+/-9 microm) were prepared and their biomechanics and pharmacological reactivities were tested using pressure arteriography ex vivo. The spontaneous tone of quercetin-treated arteries was higher (16.5+/-1.9 % vs. 12.9+/-0.9 %), which resulted in a reduced lumen size (144+/-9 microm vs. 167+/-12 microm), thicker vascular wall (22.6+/-1.8 microm vs. 17.4+/-1.6 microm) and decreased tangential wall stress (16.8+/-1.1 kPa vs. 20.5+/-1.6 kPa) in supplemented animals (in spontaneous tone at 50 mm Hg, p<0.01 in all these comparisons). Elevated basal NO release resulted in increased endothelial dilation in quercetin-treated animals, especially at higher intraluminal pressures (10.8+/-2.5 % vs. 5.7+/-1.3 % at 70 mm Hg, p<0.01). We found remodeling of the geometry of coronary arterioles to ensure higher dilatory reserve and nitrogen monoxide production, as well as lowered elastic stress of the vessel wall.

650    _2

$a zvířata $7 D000818

650    _2

$a koronární cévy $x účinky léků $x fyziologie $7 D003331

650    _2

$a rozvrh dávkování léků $7 D004334

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a quercetin $x aplikace a dávkování $7 D011794

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani Wistar $7 D017208

650    _2

$a remodelace cév $x účinky léků $x fyziologie $7 D066253

650    _2

$a vazodilatace $x účinky léků $x fyziologie $7 D014664

650    _2

$a vazodilatancia $x aplikace a dávkování $7 D014665

655    _2

$a časopisecké články $7 D016428

700    1_

$a Kiss, F. $u Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary

700    1_

$a Restifo, J. M. $u Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary; Faculty of Pharmacy, University of Palermo, Palermo, Italy

700    1_

$a Monos, E. $u Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary

700    1_

$a Nadasy, G. L. $u Department of Physiology, Semmelweis University, Budapest, Hungary

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 66, č. 4 (2017), s. 591-599

856    41

$u https://pubmed.ncbi.nlm.nih.gov/28406703 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y 4 $z 0

990    __

$a 20180611 $b ABA008

991    __

$a 20180619094742 $b ABA008

999    __

$a ok $b bmc $g 1311772 $s 1017930

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 66 $c 4 $d 591-599 $e 20170412 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK118 $a Pubmed-20180611